House Dems Seek Tougher Drug Trial Reporting Rules

Law360, New York (May 17, 2013, 5:18 PM EDT) -- A group of House Democrats, including the ranking member of the Energy and Commerce Committee, introduced a bill Thursday that would expand the federal clinical trials database, impose stricter reporting requirements for clinical trials and add information about foreign trials.

“This legislation will bring to light critical additional information about clinical trials that companies are not currently required to disclose,” Energy and Commerce Committee Ranking Member Henry Waxman, D-Calif., said in a statement. "It also clarifies that all clinical trials used to support an application for...
To view the full article, register now.